Results 131 to 140 of about 33,653 (199)

Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression. [PDF]

Oncotarget, 2016
Ciardiello C, Roca MS, Noto A, Bruzzese F, Moccia T, Vitagliano C, Di Gennaro E, Ciliberto G, Roscilli G, Aurisicchio L, Marra E, Mancini R, Budillon A, Leone A.   +13 more
europepmc   +1 more source

Human Mesenchymal Stromal Cells Derived from Different Tissues Show Similar Profiles of c-ErbB Receptor Family Expression at the mRNA and Protein Levels. [PDF]

Int J Mol Sci
Kosheverova V, Kharchenko M, Kamentseva R, Kotov M, Schwarz A, Kuneev I, Kotova A, Enukashvily N, Kornilova E.   +8 more
europepmc   +1 more source

Lipids regulate epidermal growth factor receptor activation by its ligands. [PDF]

Biochem Soc Trans
Hutchison JM, Lemmon MA.
europepmc   +1 more source

Expression and function of ErbB receptors and ligands in the pituitary. [PDF]

Endocr Relat Cancer, 2011
Cooper O, Vlotides G, Fukuoka H, Greene MI, Melmed S.   +4 more
europepmc   +1 more source

Single-cell profiling of ERBB family receptors identifies ERBB3 as a key regulator in head and neck squamous cell carcinoma progression. [PDF]

Discov Oncol
Luo Y, Li Y, Liu S, Hu R, Wu J.
europepmc   +1 more source

Phosphoproteomic analysis reveals the diversity of signaling behind ErbB-inhibitor-induced phenotypes. [PDF]

FEBS J
Vaparanta K, Song Z, Farahani I, Jokilammi A, Merilahti J, Örling J, Virtanen N, Haapaniemi P, Sahlgren C, Elenius K, Paatero I.   +10 more
europepmc   +1 more source

ERBB receptors in cancer: signaling from the inside. [PDF]

Breast Cancer Res, 2011
Arteaga CL.
europepmc   +1 more source

Integrated bioinformatics and network search identify biomarkers and comorbid mechanisms of atrial fibrillation and ischemic stroke. [PDF]

Medicine (Baltimore)
Liu B, Zhou X, Cai H, Zhu X, Xu Y, Wu J, Huang S, Zhou L, Weng H, Luo D.   +9 more
europepmc   +1 more source

KRAS mutated lung adenocarcinoma responds to pan-ERBB and Aurora kinase inhibitors. [PDF]

NPJ Precis Oncol
Uras IZ, Trkulja MV, Salama AKAA, Horvath J, Asnani K, Trenk C, Kubicek S, Bilban M, Moll HP, Casanova E.   +9 more
europepmc   +1 more source

Promoter-level expression clustering identifies time development of transcriptional regulatory cascades initiated by ErbB receptors in breast cancer cells. [PDF]

Sci Rep, 2015
Mina M, Magi S, Jurman G, Itoh M, Kawaji H, Lassmann T, Arner E, Forrest ARR, Carninci P, Hayashizaki Y, Daub CO, FANTOM Consortium, Okada-Hatakeyama M, Furlanello C.   +13 more
europepmc   +1 more source